Cargando…

Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges

The cytogenetic abnormalities and molecular mutations involved in acute myeloid leukemia (AML) lead to unique treatment challenges. Although adoptive T-cell therapies (ACT) such as chimeric antigen receptor (CAR) T-cell therapy have shown promising results in the treatment of leukemias, especially B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Synat, Li, Yisheng, Qiao, Jingqiao, Meng, Xiangyu, He, Ziqian, Gao, Xuefeng, Yu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959347/ https://www.ncbi.nlm.nih.gov/pubmed/35356211 http://dx.doi.org/10.3389/fonc.2022.787108

Ejemplares similares

The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia
por: Han, Caixia, et al.
Publicado: (2021)

CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
por: Mardiana, Sherly, et al.
Publicado: (2020)

TCR-T Immunotherapy: The Challenges and Solutions
por: Liu, Yating, et al.
Publicado: (2022)

Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions
por: Greenbaum, Uri, et al.
Publicado: (2020)

Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype
por: Kang, Synat, et al.
Publicado: (2022)

Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins
por: Zhang, Juan, et al.
Publicado: (2021)

Developments and challenges of FLT3 inhibitors in acute myeloid leukemia
por: Ge, Shuai-Shuai, et al.
Publicado: (2022)

Epigenetic silencing of UBXN8 contributes to leukemogenesis in t(8;21) acute myeloid leukemia
por: Yang, Erna, et al.
Publicado: (2021)

Characteristics of Cohesin Mutation in Acute Myeloid Leukemia and Its Clinical Significance
por: Han, Caixia, et al.
Publicado: (2021)

Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
por: Zhou, Weijun, et al.
Publicado: (2022)

The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
por: Kang, Synat, et al.
Publicado: (2021)

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
por: Molica, Matteo, et al.
Publicado: (2021)

Editorial: Surgical oncology in the elderly: the state of the art and future challenges
por: Sperti, Cosimo, et al.
Publicado: (2023)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma
por: He, Shujiao, et al.
Publicado: (2022)

Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia
por: Zha, Xianfeng, et al.
Publicado: (2012)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
por: Chang, Ying-Jun, et al.
Publicado: (2021)

Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023)

Azacitidine and donor lymphocyte infusion for patients with relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic stem cell transplantation: A meta-analysis
por: Li, Xuefeng, et al.
Publicado: (2022)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells
por: Chen, Yilin, et al.
Publicado: (2021)

Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia
por: Campillo-Davo, Diana, et al.
Publicado: (2021)

Therapeutic targeting of PRAME with (mTCR)CAR T cells in acute myeloid leukemia
por: Kirkey, Danielle C., et al.
Publicado: (2022)

Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues
por: Sapino, Anna, et al.
Publicado: (2013)

Genomics of Acute Myeloid Leukemia: The Next Generation
por: Riva, Laura, et al.
Publicado: (2012)

Management of Chronic Myeloid Leukemia in Advanced Phase
por: Bonifacio, Massimiliano, et al.
Publicado: (2019)

Clinical Implications of Inflammation in Acute Myeloid Leukemia
por: Récher, Christian
Publicado: (2021)

Debating Frontline Therapy in Chronic Myeloid Leukemia
por: Bi, Xia, et al.
Publicado: (2021)

Editorial: Advances in the treatment of chronic myeloid leukemia
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2023)

Editorial: Precision medicine for acute myeloid leukemia
por: Marconi, Giovanni, et al.
Publicado: (2023)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia
por: Pulikkan, John Anto, et al.
Publicado: (2018)

Harnessing the Metabolic Vulnerabilities of Leukemia Stem Cells to Eradicate Acute Myeloid Leukemia
por: Kumar, Bijender
Publicado: (2021)

Anti-Tumor Effects of BDH1 in Acute Myeloid Leukemia
por: Han, Fei, et al.
Publicado: (2021)

Methylation of SPRED1: A New Target in Acute Myeloid Leukemia
por: Su, Nan, et al.
Publicado: (2022)

Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia
por: Pan, Jingjing, et al.
Publicado: (2022)

Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia
por: Zhou, Cheng, et al.
Publicado: (2022)

The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
por: Zhuang, Xiaomei, et al.
Publicado: (2022)

Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges
por: Zuppone, Stefania, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jdlrr2a07in4t4mda5javoqmoj